Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast |
Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration |
NCT03063619 |
Recruiting |
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... |
Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery, Placebo Administration |
NCT02598557 |
Active, not recruiting |
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers |
Aspirin, Laboratory Biomarker Analysis, Zileuton, Placebo Administration |
NCT02348203 |
Active, not recruiting |
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma |
Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration |
NCT02965703 |
Recruiting |
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... |
Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration |
NCT02521285 |
Active, not recruiting |
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission |
Berberine Chloride, Laboratory Biomarker Analysis, Placebo Administration |
NCT02365480 |
Active, not recruiting |
Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers |
Broccoli Sprout/Broccoli Seed Extract Supplement, Laboratory Biomarker Analysis, Questionnaire Administration |
NCT03402230 |
Active, not recruiting |
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... |
Curcumin, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Placebo Administration |
NCT02782949 |
Active, not recruiting |
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis |
Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration |
NCT03278925 |
Recruiting |
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection |
Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid |
NCT02772003 |
Active, not recruiting |